2025-05-02 09:14:41
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Lincoln Pharmaceuticals Ltd posts consolidated PAT of Rs. 27.65 crores in Q2 FY24
Posted On : 2023-11-02 15:39:38( TIMEZONE : IST )
Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 164.6825 crores during the period ended September 30, 2023 as compared to Rs. 143.3103 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. 27.6542 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 19.0134 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. 13.81 for the period ended September 30, 2023 as compared to Rs. 9.49 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹ 164.6825 crs | ₹143.3103 crs |  14.91% |
| Net Profit | ₹27.6542 crs | ₹19.0134 crs | 45.45% |
| EPS | ₹13.81 | ₹9.49 | 45.52% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs. 164.6825 crores during the period ended September 30, 2023 as compared to Rs.146.3335 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.27.6542 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.23.7129 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.13.81 for the period ended September 30, 2023 as compared to Rs.11.84 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹ 164.6825 crs | ₹146.3335 crs | 12.54% |
| Net Profit | ₹27.6542 crs | ₹23.7129 crs | 16.62% |
| EPS | ₹13.81 | ₹11.84 | 16.64% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.307.9928 crores during the 6 Months period ended September 30, 2023 as compared to Rs.276.2991 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.46.6676 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.38.7245 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.23.30 for the 6 Months period ended September 30, 2023 as compared to Rs.19.33 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹307.9928 crs | ₹276.2991 crs | 11.47% |
| Net Profit | ₹46.6676 crs | ₹38.7245 crs | 20.51% |
| EPS | ₹23.30 | ₹19.33 | 20.54% |
Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 493.40 as compared to the previous close of Rs. 496.80. The total number of shares traded during the day was 6310 in over 373 trades.
The stock hit an intraday high of Rs. 526.00 and intraday low of 487.00. The net turnover during the day was Rs. 3123423.00.
